Literature DB >> 17517203

[The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children. Cut off points to identify metabolic syndrome in healthy children].

B García Cuartero1, C García Lacalle, C Jiménez Lobo, A González Vergaz, C Calvo Rey, M J Alcázar Villar, E Díaz Martínez.   

Abstract

OBJECTIVE: The aim of this study was to establish the reference values of the Homeostasis Model Assessment (HOMA) and Quantitative Insulin Sensitivity Check (QUICKI) indexes, as well as those of insulin and C-peptide levels in healthy children and adolescents with a view to determining reference percentiles to detect those at cardiovascular risk.
MATERIAL AND METHODS: A total of 372 children boys and girls of different ages and at distinct pubertal stages with normal body mass index participated in the study. Fasting glucose, insulin and C-peptide values were measured by chemiluminescence and the HOMA and QUICKI indexes were calculated.
RESULTS: Fasting glucose levels were normal in all children. The mean values obtained for each variable were (mean (SD)): fasting glucose 87(7.75) mg/dL, insulin 7.74 (5.35) microU/mL, C-peptide: 1.76 (0.79) ng/mL, HOMA index 1.72 (1.27) and QUICKI index 0.72 (0.29). All the variables progressively increased with age, with statistically significant differences between prepubertal and pubertal children. The QUICKI index showed an inverse relationship. In addition, significant differences were found between sexes. The 90th percentile for all the variables was as follows: insulin 15.05 microU/mL, C-peptide: 2.85 ng/mL, HOMA index 3.43 and QUICKI index 1.10.
CONCLUSIONS: Values of fasting glucose, insulin, C-peptide and the HOMA index significantly increased with age and pubertal stage, while the QUICKI index decreased. We defined the 90th percentile for all the parameters studied as the cut-off point to identify children at cardiovascular risk in our population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17517203     DOI: 10.1157/13102513

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  29 in total

1.  Changes in ghrelin and asymmetrical dimethylarginine in obese Mexican adolescents after six-month lifestyle intervention.

Authors:  Fengyang Huang; Blanca Estela del-Río-Navarro; José Alfredo Pérez Ontiveros; Eliseo Ruiz-Bedolla; Efraín Navarro-Olivos; Santiago Villafaña; Guadalupe Bravo; Enrique Hong
Journal:  Endocrine       Date:  2012-09-29       Impact factor: 3.633

2.  Prevalence of insulin resistance and impaired glucose tolerance in a sample of obese Spanish children and adolescents.

Authors:  M P Bahíllo-Curieses; F Hermoso-López; M J Martínez-Sopena; P Cobreros-García; P García-Saseta; M Tríguez-García; J M Marugán-Miguelsanz
Journal:  Endocrine       Date:  2011-10-01       Impact factor: 3.633

3.  Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children.

Authors:  S Murugesan; M Ulloa-Martínez; H Martínez-Rojano; F M Galván-Rodríguez; C Miranda-Brito; M C Romano; A Piña-Escobedo; M L Pizano-Zárate; C Hoyo-Vadillo; J García-Mena
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-12       Impact factor: 3.267

4.  Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents.

Authors:  Carlos Juárez-López; Miguel Klünder-Klünder; Patricia Medina-Bravo; Adrián Madrigal-Azcárate; Eliezer Mass-Díaz; Samuel Flores-Huerta
Journal:  BMC Public Health       Date:  2010-06-07       Impact factor: 3.295

5.  DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance.

Authors:  M C García-Cardona; F Huang; J M García-Vivas; C López-Camarillo; B E Del Río Navarro; E Navarro Olivos; E Hong-Chong; F Bolaños-Jiménez; L A Marchat
Journal:  Int J Obes (Lond)       Date:  2014-02-19       Impact factor: 5.095

6.  Inappropriate Use of Homeostasis Model Assessment Cutoff Values for Diagnosing Insulin Resistance in Pediatric Studies.

Authors:  Carrie Fox; Lourdes Bernardino; Jill Cochran; Mary Essig; Kristie Grove Bridges
Journal:  J Am Osteopath Assoc       Date:  2017-11-01

7.  β-cell function is associated with metabolic syndrome in Mexican subjects.

Authors:  Blanca G Baez-Duarte; María Del Carmen Sánchez-Guillén; Ricardo Pérez-Fuentes; Irma Zamora-Ginez; Bertha Alicia Leon-Chavez; Cristina Revilla-Monsalve; Sergio Islas-Andrade
Journal:  Diabetes Metab Syndr Obes       Date:  2010-08-30       Impact factor: 3.168

8.  Growth hormone treatment does not to lead to insulin resistance nor excessive rise in IGF-1 levels, while improving height in patients small for gestational age A long-term observational study.

Authors:  Juan P López-Siguero; Maria J Martínez-Aedo; Jose Antonio Bermúdez de la Vega; Jordi Bosch-Muñoz; Alfonso M Lechuga-Sancho; Triana Villalobos
Journal:  Clin Endocrinol (Oxf)       Date:  2021-12-09       Impact factor: 3.523

9.  Adiponectin in eutrophic and obese children as a biomarker to predict metabolic syndrome and each of its components.

Authors:  Miguel Klünder-Klünder; Samuel Flores-Huerta; Rebeca García-Macedo; Jesús Peralta-Romero; Miguel Cruz
Journal:  BMC Public Health       Date:  2013-01-30       Impact factor: 3.295

10.  Analysis of the contribution of FTO, NPC1, ENPP1, NEGR1, GNPDA2 and MC4R genes to obesity in Mexican children.

Authors:  Aurora Mejía-Benítez; Miguel Klünder-Klünder; Loic Yengo; David Meyre; Celia Aradillas; Esperanza Cruz; Elva Pérez-Luque; Juan Manuel Malacara; Maria Eugenia Garay; Jesús Peralta-Romero; Samuel Flores-Huerta; Jaime García-Mena; Philippe Froguel; Miguel Cruz; Amélie Bonnefond
Journal:  BMC Med Genet       Date:  2013-02-01       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.